Getting your player ready...
LONDON — A new and unlicensed treatment for swine flu could be used in patients who have Tamiflu-resistant viruses, doctors say.
In an article published today in the medical journal Lancet, British doctors describe how they used an intravenous form of the antiviral Relenza to treat a 22-year- old woman who had a severe case of swine flu. Relenza is usually inhaled via the nose, and is not licensed to be given intravenously.
The woman recently had undergone chemotherapy for Hodgkin’s disease. After she caught swine flu, her lungs filled with fluid. She was not responding to inhaled versions of the drug, so her doctors tried a different way of getting the drug into her body. The Associated Press
